Case Studies

Speyside has partnered with a global healthcare company since 2019 to track and report key healthcare topics in emerging markets, providing alerts, insights, and engagement recommendations. Through a recurring monitoring system, local teams have been able to anticipate opportunities and risks, align actions, and support affiliates in shaping sentiment, advocating for change, and contributing data to key healthcare discussions.

Speyside helped a global pharmaceutical company build a unified rare diseases narrative across six LATAM countries, creating tailored key messages, a Rare Diseases Index, country reports, and policy recommendations—equipping regional teams to lead strategic conversations and engage key stakeholders effectively.

Speyside supported a global pharmaceutical company in assessing Argentina, Colombia, and Mexico’s, readiness for a lung cancer screening program. The project involved analyzing the regulatory landscape, identifying policy gaps, and collaborating with advocacy groups and the scientific community to develop actionable recommendations. Deliverables included a saved lives calculator, communications toolkit, policy report, and a recommendations blueprint to guide future policymaker engagement.

Speyside team helped a global pharmaceutical company strengthen local teams in emerging markets to improve access to early screening and management of cardiorenal complications of type 2 diabetes in five high-growth markets, delivering a master policy-shaping plan, tailored national strategies, stakeholder maps, and support for local implementation.